Finding
the Right
Partner
for You!

Finding
the Right
Partner
for You!

Commercial Healthcare Partners

Commercial Healthcare Partners is dedicated to the creation of mutually beneficial partnerships within the pharmaceutical and bio-technology industries.  Whether your organization has products, compounds, or technology to license out or has an interest in acquiring such resources, Commercial Healthcare Partners can help.
Our extensive network is at your disposal.

Commercial Healthcare Partners has developed strategic partnerships with other pharma-licensing organizations in the U.S., Europe and Latin America.  This strengthens our ability to fully meet your licensing, commercialization, and partnering search needs.

How can we assist you in meeting your licensing, commercialization, and partnering needs?

Opportunities with CHP

Manufacturing Opportunities

We have a Non-cGMP API starting material company with operations in Jaipur, India and Birmingham, Alabama. 14 years old, $33 Million in 2021 sales, $20 million EBITDA. 120 staff, long term relationships with US / Japanese client base. I’m looking for x9 EBITDA.

Private-Equity owned, Phase III plasma-derived therapeutic company is ready to build the commercial facility with One Million Liter annual capacity, in Dallas Texas, with $1.5 Billion in future annual revenue. We are looking for $60-240 Million depending on the investment levels.

Self-amplifying RNA (saRNA) Virtual Biotech seeks VC investment to develop a pipeline of RNA therapeutics and vaccines. We are looking for $6-10 million for pre-series A investment.

University-owned high-throughput, nanoparticle processing technology company. Experience with inline processing and concentrating systems provides unique capabilities, they offer a robust, continuous platform for nanoparticle concentration and sterile filtration. We are looking for $1-3 million for seed investment.

Oral Solid Dose (OSD) Tablets & Capsules facility, 45 minutes from Boston, with $20 million in facility value / equipment. Hand full of active customers, $2-3 Million in annual sales, break even EBITDA, 40,000 Sqft, 2,500 cGMP, DEA license, and FDA approved. Limited staff of around 10. We are looking for $8 million for the real estate & business.

CHP maintains a list of ANDAs available for in-licensing.

Many of these assets are turn-key and can be acquired outright.  Some of them require tech-transfer.

All of them have Master Drug Files that will be conveyed to the licensor or acquirer.

CHP will assist in determining the level of support needed including the source of API and manufacturing arrangements.

Looking for appropriate candidates to license in can be time consuming and use resources.

More important, the search often results in identification of product with profiles that do not fit your needs. Commercial Healthcare Partners can save time and effort by conducting custom searches specific to your specifications. We accept only those assignments where we believe we can deliver value.

An initial discussion will help define your needs, whether CHP can help, and our working relationship. There are several options for working with Commercial Healthcare Partners:

• A retained search
• Contingency search
• Custom arrangement

Finding an appropriate partner to commercialize a product in research often requires finesse.

Identification of a partner is merely the starting point in the context of a more complex process that often involves due diligence, negotiation, multiple meetings and presentations. Commercial Healthcare Partners maintains an extensive network of contacts within the pharmaceutical and biotechnology industries.

An initial consultation can help define your needs, whether we are an appropriate search partner for your product or technology, and how we can effectively work together.

We accept only those assignments where we can deliver value. We offer several search options:

• Retained Search
• Contingency Search
• Listing service
• Custom arrangement

28 Jan 2020
Approved 505(b)(2) available for in-licensing:

CHP is pleased to announce the availability of an approved 505(b)(2) product in the cardiovascular space.  US rights only.

Asset has significant intellectual property rights.

This product is ideally suited for a company with a sales force calling on primary care providers and cardiologists.

Samples and inventory, supply and manufacturing agreements are in place.

Completed Projects

We are the Best at what we do!

If you want to be impressed then do not hesitate and write us an email!
Or Call (615) 887-3847

Areas of expertise

Business Development

Pharma Asset Sales

Commercialization

Partner Sourcing

BUSINESS DEVELOPMENT

Commercial Healthcare Partners will engage in a dialogue to discern the ideal profile of a partner for you.

PHARMA ASSET SALES

Commercial Healthcare Partners will engage in a dialogue to discern the ideal profile of a partner for you.

COMMERCIALIZATION

Commercial Healthcare Partners will engage in a dialogue to discern the ideal profile of a partner for you.

PARTNER SOURCING

Commercial Healthcare Partners will engage in a dialogue to discern the ideal profile of a partner for you.